Arrowhead Pharmaceuticals
ARWR
41.37
-2.28
-5.22%
Arrowhead Pharmaceuticals
US · ARWR
#1569 by market cap
Listed 1970
41.37
-2.28
-5.22%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
A Quick Look at Today's Ratings for Arrowhead Pharmaceuticals(ARWR.US), With a Forecast Between $89.59 to $126Market Newswire · 2026/8/5
-
Rating change
Goldman Sachs Maintains Arrowhead Pharmaceuticals(ARWR.US) With Hold Rating, Cuts Target Price to $74Market Newswire · 2026/9/24
-
Rating change
RBC Capital Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $100Market Newswire · 2026/8/31
-
Rating change
A Quick Look at Today's Ratings for Arrowhead Pharmaceuticals(ARWR.US), With a Forecast Between $108 to $126Market Newswire · 2026/10/15
-
A Quick Look at Today's Ratings for Arrowhead Pharmaceuticals(ARWR.US), With a Forecast Between $96 to $126Market Newswire · 2026/11/14
-
Piper Sandler Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $126Market Newswire · 2026/11/10
-
Rating change
J.P. Morgan Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy RatingMarket Newswire · 2026/10/15
-
Rating change
BofA Securities Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $100Market Newswire · 2026/10/12
-
Rating change
Citi Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy RatingMarket Newswire · 2026/9/16
-
Rating change
Analysts Are Bullish on Top Healthcare Stocks: CapsoVision, Inc. (CV), Arrowhead Pharmaceuticals (ARWR)TipRanks · 2026/8/31
-
Rating change
J.P. Morgan Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $100Market Newswire · 2026/8/7
-
Rating change
Citi Initiates Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Announces Target Price $108Market Newswire · 2026/9/8
-
Rating change
TD Cowen Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy RatingMarket Newswire · 2026/8/31
-
Rating change
Morgan Stanley Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $120Market Newswire · 2026/9/1
-
Stifel Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Cuts Target Price to $96Market Newswire · 2026/11/13
-
Rating change
Citi Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $108Market Newswire · 2026/9/9
-
Rating change
H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $120Market Newswire · 2026/8/7
-
H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $120Market Newswire · 2026/11/11
-
Rating change
Stifel Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $104Market Newswire · 2026/8/31
-
B. Riley Securities Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $123Market Newswire · 2026/11/10
-
Rating change
B. Riley Securities Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $123Market Newswire · 2026/7/30
-
Rating change
RBC Capital Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $100Market Newswire · 2026/7/31
-
Rating change
B. Riley Securities Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $123Market Newswire · 2026/8/5
-
H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $120Market Newswire · 2026/10/16
-
Piper Sandler Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $126Market Newswire · 2026/10/16
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Arrowhead Pharmaceuticals discussion 0 comments